{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:38:16Z","timestamp":1791041896238,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"FWO senior clinical investigator grant","award":["1806421N"],"award-info":[{"award-number":["1806421N"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-82052-z","type":"journal-article","created":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T03:26:10Z","timestamp":1735356370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Belgian single centre outcome study of radioiodine treatment in adolescents with Graves\u2019 disease"],"prefix":"10.1038","volume":"14","author":[{"given":"Laura","family":"Chielens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Nauwynck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem","family":"Staels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Vanbesien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Gies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Everaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"De Schepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,28]]},"reference":[{"key":"82052_CR1","first-page":"CD006294","volume":"3","author":"C Ma","year":"2008","unstructured":"Ma, C., Kuang, A., Xie, J. & Liu, G. Radioiodine treatment for pediatric Graves\u2019 disease. Cochrane Database Syst. Rev. 3, CD006294 (2008).","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"82052_CR2","first-page":"143","volume":"65","author":"O Marques","year":"2018","unstructured":"Marques, O., Antunes, A. & Oliveira, M. J. Treatment of Graves\u2019 disease in children: The Portuguese experience. Endocrinol. Diabetes Nutr. (Engl Ed). 65 (3), 143\u2013149 (2018).","journal-title":"Endocrinol. Diabetes Nutr. (Engl Ed)"},{"issue":"6","key":"82052_CR3","doi-asserted-by":"publisher","first-page":"661","DOI":"10.5603\/EP.a2021.0092","volume":"72","author":"A Kr\u00f3l","year":"2021","unstructured":"Kr\u00f3l, A., Czarniecka, A. & Jarz\u0105b, B. Definitive treatment of Graves\u2019 disease in children and adolescents. Endokrynol Pol. 72 (6), 661\u2013665 (2021).","journal-title":"Endokrynol Pol."},{"issue":"3","key":"82052_CR4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1515\/jpem-2015-0333","volume":"29","author":"RZ Cohen","year":"2016","unstructured":"Cohen, R. Z., Felner, E. I., Heiss, K. F., Wyly, J. B. & Muir, A. B. Outcomes analysis of radioactive iodine and total thyroidectomy for pediatric Graves\u2019 disease. J. Pediatr. Endocrinol. Metab. 29 (3), 319\u2013325 (2016).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"4","key":"82052_CR5","doi-asserted-by":"publisher","first-page":"541","DOI":"10.4158\/EP10257.OR","volume":"17","author":"AP Cemeroglu","year":"2011","unstructured":"Cemeroglu, A. P., Kleis, L., Wood, M. A. & Davis, A. T. Reliability of early iodine 123 uptake for treatment of Graves disease in children. Endocr. Pract. 17 (4), 541\u2013545 (2011).","journal-title":"Endocr. Pract."},{"issue":"9","key":"82052_CR6","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1515\/JPEM.2006.19.9.1095","volume":"19","author":"SA Rivkees","year":"2006","unstructured":"Rivkees, S. A. The treatment of Graves\u2019 disease in children. J. Pediatr. Endocrinol. Metab. 19 (9), 1095\u20131111 (2006).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"9","key":"82052_CR7","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1515\/JPEM.2007.20.9.973","volume":"20","author":"T Pinto","year":"2007","unstructured":"Pinto, T., Cummings, E. A., Barnes, D. & Salisbury, S. Clinical course of pediatric and adolescent Graves\u2019 disease treated with radioactive iodine. J. Pediatr. Endocrinol. Metab. 20 (9), 973\u2013980 (2007).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"6","key":"82052_CR8","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.ando.2018.08.001","volume":"79","author":"J L\u00e9ger","year":"2018","unstructured":"L\u00e9ger, J., Oliver, I., Rodrigue, D., Lambert, A. S. & Coutant, R. Graves\u2019 disease in children. Ann. Endocrinol. (Paris). 79 (6), 647\u2013655 (2018).","journal-title":"Ann. Endocrinol. (Paris)"},{"issue":"1","key":"82052_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1067\/mpd.2002.125494","volume":"141","author":"T Nebesio","year":"2002","unstructured":"Nebesio, T., Siddiqui, A., Pescovitz, O. & Eugster, E. Time course to hypothyroidism after fixed-dose radioablation therapy of Graves. J. Pediatr. 141 (1), 99\u2013103 (2002).","journal-title":"J. Pediatr."},{"issue":"3","key":"82052_CR10","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1210\/jc.2006-1239","volume":"92","author":"SA Rivkees","year":"2007","unstructured":"Rivkees, S. A. & Dinauer, C. An optimal treatment for pediatric Graves\u2019 disease is radioiodine. J. Clin. Endocrinol. Metab. 92 (3), 797\u2013800 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"82052_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4274\/Jcrpe.951","volume":"5","author":"S Namwongprom","year":"2013","unstructured":"Namwongprom, S., Unachak, K., Dejkhamron, P., Ua-apisitwong, S. & Ekmahachai, M. Radioactive iodine for thyrotoxicosis in childhood and adolescence: Treatment and outcomes. J. Clin. Res. Pediatr. Endocrinol. 5 (2), 95\u201397 (2013).","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"issue":"2","key":"82052_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/cen.12871","volume":"85","author":"T Cheetham","year":"2016","unstructured":"Cheetham, T. & Bliss, R. Treatment options in the young patient with Graves\u2019 disease. Clin. Endocrinol. (Oxf). 85 (2), 161\u2013164 (2016).","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"7\u20138","key":"82052_CR13","first-page":"797","volume":"28","author":"JD West","year":"2015","unstructured":"West, J. D., Cheetham, T. D., Dane, C. & Natarajan, A. Should radioiodine be the first-line treatment for paediatric Graves\u2019 disease? J. Pediatr. Endocrinol. Metab. 28 (7\u20138), 797\u2013804 (2015).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"2","key":"82052_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1515\/jpem-2017-0394","volume":"31","author":"F Azizi","year":"2018","unstructured":"Azizi, F. & Amouzegar, A. Management of thyrotoxicosis in children and adolescents: 35 years\u2019 experience inin 304 patients. J. Pediatr. Endocrinol. Metab. 31 (2), 159\u2013165 (2018).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"3","key":"82052_CR15","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1210\/jc.2010-0898","volume":"96","author":"AJ Bauer","year":"2011","unstructured":"Bauer, A. J. Approach to the pediatric patient with Graves\u2019 disease: When is definitive therapy warranted? J. Clin. Endocrinol. Metab. 96 (3), 580\u2013588 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"82052_CR16","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s00431-009-0992-2","volume":"168","author":"M Chao","year":"2009","unstructured":"Chao, M. et al. Radioiodine treatment for pediatric hyperthyroid grave\u2019s disease. Eur. J. Pediatr. 168 (10), 1165\u20131169 (2009).","journal-title":"Eur. J. Pediatr."},{"issue":"3","key":"82052_CR17","doi-asserted-by":"publisher","first-page":"456","DOI":"10.4158\/EP.17.3.456","volume":"17","author":"RS Bahn","year":"2011","unstructured":"Bahn, R. S. et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr. Pract. 17 (3), 456\u2013520 (2011).","journal-title":"Endocr. Pract."},{"issue":"1","key":"82052_CR18","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-21-0073","volume":"11","author":"CF Mooij","year":"2022","unstructured":"Mooij, C. F. et al. European Thyroid Association Guideline for the management of pediatric Graves\u2019 disease. Eur. Thyroid J. 11 (1), e210073 (2022).","journal-title":"Eur. Thyroid J."},{"issue":"3","key":"82052_CR19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1515\/jpem-2019-0316","volume":"33","author":"PB Kaplowitz","year":"2020","unstructured":"Kaplowitz, P. B., Jiang, J. & Vaidyanathan, P. Radioactive iodine therapy for pediatric Graves\u2019 disease: A single-center experience over a 10-year period. J. Pediatr. Endocrinol. Metab. 33 (3), 383\u2013389 (2020).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"82052_CR20","doi-asserted-by":"crossref","unstructured":"Turner, N., Driver, I., Salotti, J. A., Pearce, M. S. & Cheetham, T. Increasing use of radioiodine in young people with thyrotoxicosis in Great Britain. Eur. J. Endocrinol. 167 (5), (2012).","DOI":"10.1530\/EJE-12-0542"},{"issue":"1","key":"82052_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/archdischild-2021-323049","volume":"107","author":"J Tonge","year":"2022","unstructured":"Tonge, J. & Soundararajan, K. Is radioiodine a better therapy than antithyroid drugs for achieving remission in those with juvenile Graves\u2019 hyperthyroidism?. Arch. Dis. Child. 107 (1), 97\u201399 (2022).","journal-title":"Arch. Dis. Child."},{"issue":"1","key":"82052_CR22","first-page":"39","volume":"10","author":"AS Zaat","year":"2021","unstructured":"Zaat, A. S., Derikx, J. P. M., Zwaveling-Soonawala, N., van Trotsenburg, A. S. P. & Mooij, C. F. Thyroidectomy in pediatric patients with Graves\u2019 Disease: A systematic review of postoperative morbidity. Eur. Thyroid J. 10 (1), 39\u201351 (2021).","journal-title":"Eur. Thyroid J."},{"issue":"24","key":"82052_CR23","first-page":"00699","volume":"S0039\u20136060","author":"EA Engelbrecht-Wiggans","year":"2024","unstructured":"Engelbrecht-Wiggans, E. A. et al. Long-term retreatment outcomes after definitive management of Graves\u2019 disease with radioactive iodine versus surgery. Surgery. S0039\u20136060 (24), 00699\u201300698 (2024).","journal-title":"Surgery"},{"issue":"2","key":"82052_CR24","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1530\/EJE-21-0077","volume":"185","author":"JM van Lieshout","year":"2021","unstructured":"van Lieshout, J. M., Mooij, C. F., van Trotsenburg, A. S. P. & Zwaveling-Soonawala, N. Methimazole-induced remission rates in pediatric Graves\u2019 disease: A systematic review. Eur. J. Endocrinol. 185 (2), 219\u2013229 (2021).","journal-title":"Eur. J. Endocrinol."},{"key":"82052_CR25","doi-asserted-by":"publisher","first-page":"687834","DOI":"10.3389\/fendo.2021.687834","volume":"12","author":"A Song","year":"2021","unstructured":"Song, A. et al. Long-term antithyroid drug treatment of Graves\u2019 disease in children and adolescents: A 20-year single-center experience. Front. Endocrinol. (Lausanne). 12, 687834 (2021).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"82052_CR26","doi-asserted-by":"publisher","first-page":"101631","DOI":"10.1016\/j.beem.2022.101631","volume":"37","author":"F Azizi","year":"2023","unstructured":"Azizi, F., Abdi, H., Amouzegar, A. & Habibi Moeini, A. S. Long-term thionamide antithyroid treatment of Graves\u2019 disease. Best Pract. Res. Clin. Endocrinol. Metab. 37, 101631 (2023).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"6","key":"82052_CR27","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/cen.14869","volume":"98","author":"D Puttawong","year":"2023","unstructured":"Puttawong, D. et al. Long-term outcomes of anti-thyroid drug treatment in childhood-onset Graves\u2019 disease. Clin. Endocrinol. (Oxf). 98 (6), 823\u2013831 (2023).","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"1","key":"82052_CR28","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1210\/jc.2011-1944","volume":"97","author":"J L\u00e9ger","year":"2012","unstructured":"L\u00e9ger, J., Gelwane, G., Kaguelidou, F., Benmerad, M. & Alberti, C. Positive impact of long-term antithyroid drug treatment on the outcome of children with Graves\u2019 disease: National long-term cohort study. J. Clin. Endocrinol. Metab. 97 (1), 110\u2013119 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"82052_CR29","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1210\/clinem\/dgac573","volume":"107","author":"SA Rivkees","year":"2022","unstructured":"Rivkees, S. A. Approach to the patient: Management and the long-term consequences of Graves\u2019 disease in children. J. Clin. Endocrinol. Metab. 107 (12), 3408\u20133417 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"82052_CR30","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/cen.13099","volume":"85","author":"S Rabon","year":"2016","unstructured":"Rabon, S., Burton, A. M. & White, P. C. Graves\u2019 disease in children: Long-term outcomes of medical therapy. Clin. Endocrinol. (Oxf). 85 (4), 632\u2013635 (2016).","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"6","key":"82052_CR31","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1111\/j.1365-2265.2009.03565.x","volume":"71","author":"S McCormack","year":"2009","unstructured":"McCormack, S. et al. Radioactive iodine for hyperthyroidism in children and adolescents: Referral rate and response to treatment. Clin. Endocrinol. (Oxf). 71 (6), 884\u2013891 (2009).","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"4 Pt 1","key":"82052_CR32","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1542\/peds.111.4.745","volume":"11","author":"SA Rivkees","year":"2003","unstructured":"Rivkees, S. A., & Cornelius, E. A. Influence of iodine-131 dose on the outcome of hyperthyroidism in children. Pediatrics 11 (4 Pt 1), 745\u2013749 (2003).","journal-title":"Pediatrics"},{"issue":"1","key":"82052_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1687-9856-2011-14","volume":"2011","author":"N Nakatake","year":"2011","unstructured":"Nakatake, N., Fukata, S. & Tajiri, J. Prediction of post-treatment hypothyroidism using changes in thyroid volume after radioactive iodine therapy in adolescent patients with Graves\u2019 disease. Int. J. Pediatr. Endocrinol. 2011 (1), 14 (2011).","journal-title":"Int. J. Pediatr. Endocrinol."},{"issue":"3","key":"82052_CR34","first-page":"442","volume":"36","author":"JD Clark","year":"1995","unstructured":"Clark, J. D., Gelfand, M. J. & Elgazzar, A. H. Iodine-131 therapy of hyperthyroidism in pediatric patients. J. Nucl. Med. 36 (3), 442\u2013445 (1995).","journal-title":"J. Nucl. Med."},{"issue":"5","key":"82052_CR35","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1159\/000517174","volume":"10","author":"SL Lutterman","year":"2021","unstructured":"Lutterman, S. L. et al. The efficacy and short- and long-term side effects of radioactive iodine treatment in pediatric Graves\u2019 disease: A systematic review. Eur. Thyroid J. 10 (5), 353\u2013363 (2021).","journal-title":"Eur. Thyroid J."},{"issue":"2","key":"82052_CR36","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1365-2265.2006.02574.x","volume":"65","author":"M Tondeur","year":"2006","unstructured":"Tondeur, M., Glinoer, D., Sand, A., Verelst, J. & Ham, H. Variability of the administered radioiodine doses for the treatment of hyperthyroidism in Belgium. Clin. Endocrinol. (Oxf). 65 (2), 206\u2013209 (2006).","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"2","key":"82052_CR37","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s12020-023-03371-1","volume":"81","author":"M Jawwad","year":"2023","unstructured":"Jawwad, M. et al. Long-term outcome of treatments for Graves disease in the children and adolescent population. Endocrine 81 (2), 223\u2013230 (2023).","journal-title":"Endocrine"},{"issue":"1","key":"82052_CR38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1530\/EC-12-0049","volume":"2","author":"AN Cury","year":"2012","unstructured":"Cury, A. N. et al. Clinical experience with radioactive iodine in the treatment of childhood and adolescent Graves\u2019 disease. Endocr. Connect. 2 (1), 32\u201337 (2012).","journal-title":"Endocr. Connect."},{"issue":"3","key":"82052_CR39","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s40618-020-01339-w","volume":"44","author":"S Namwongprom","year":"2021","unstructured":"Namwongprom, S., Dejkhamron, P. & Unachak, K. Success rate of radioactive iodine treatment for children and adolescent with hyperthyroidism. J. Endocrinol. Invest. 44 (3), 541\u2013545 (2021).","journal-title":"J. Endocrinol. Invest."},{"issue":"1","key":"82052_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00247-022-05415-6","volume":"53","author":"AT Trout","year":"2023","unstructured":"Trout, A. T. et al. Radioiodine treatment of pediatric Graves disease: A multicenter review. Pediatr. Radiol. 53 (1), 1\u201327 (2023).","journal-title":"Pediatr. Radiol."},{"issue":"5","key":"82052_CR41","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/j.1365-2265.1983.tb00037.x","volume":"19","author":"L Heged\u00fcs","year":"1983","unstructured":"Heged\u00fcs, L., Hansen, J. M. & Karstrup, S. High incidence of normal thyroid gland volume in patients with Graves\u2019 disease. Clin. Endocrinol. (Oxf). 19 (5), 603\u2013607 (1983).","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"5","key":"82052_CR42","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1159\/000320028","volume":"74","author":"SA Rivkees","year":"2010","unstructured":"Rivkees, S. A. Pediatric Graves\u2019 disease: Controversies in management. Horm. Res. Paediatr. 74 (5), 305\u2013311 https:\/\/doi.org\/10.1159\/000320028 (2010).","journal-title":"Horm. Res. Paediatr."},{"issue":"11","key":"82052_CR43","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.1007\/s00431-023-05153-3","volume":"182","author":"M Sheremeta","year":"2023","unstructured":"Sheremeta, M. et al. Thyroid volume is the key predictor of hyperthyroidism remission after radioactive iodine therapy in pediatric patients. Eur. J. Pediatr. 182 (11), 4931\u20134937 (2023).","journal-title":"Eur. J. Pediatr."},{"issue":"4","key":"82052_CR44","first-page":"132","volume":"22","author":"L Ward","year":"1999","unstructured":"Ward, L. et al. Outcome of pediatric Graves\u2019 disease after treatment with antithyroid medication and radioiodine. Clin. Invest. Med. 22 (4), 132\u2013139 (1999).","journal-title":"Clin. Invest. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82052-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82052-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82052-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T17:02:51Z","timestamp":1735405371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82052-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,28]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["82052"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-82052-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,28]]},"assertion":[{"value":"25 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31063"}}